Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2014 (2014), Article ID 912418, 7 pages
http://dx.doi.org/10.1155/2014/912418
Review Article

The Treatment of Peritoneal Carcinomatosis in Advanced Gastric Cancer: State of the Art

1General Surgery Department, Spedali Civili, Chirurgia Generale 3, Piazzale Spedali Civili, 25121 Brescia, Italy
2General Surgery Department, Papa Giovanni XXIII Hospital, 42121 Bergamo, Italy
3Emergency Surgery Department, Ospedale Maggiore, 43121 Parma, Italy

Received 18 July 2013; Revised 20 November 2013; Accepted 2 January 2014; Published 17 February 2014

Academic Editor: George H. Sakorafas

Copyright © 2014 Giulia Montori et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Bertuccio, L. Chatenoud, F. Levi et al., “Recent patterns in gastric cancer: a global overview,” International Journal of Cancer, vol. 125, no. 3, pp. 666–673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Okines, M. Verheij, W. Allum, D. Cunningham, and A. Cervantes, “Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 21, no. 5, pp. v50–v54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Nissan, A. Garofalo, and J. Esquivel, “Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) for gastric adenocarcinoma: why haven't we reached the promised land?” Journal of Surgical Oncology, vol. 102, no. 5, pp. 359–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Glehen, F. Mohamed, and F. N. Gilly, “Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia,” The Lancet Oncology, vol. 5, no. 4, pp. 219–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. S. Gill, D. P. Al-Adra, J. Nagendran et al., “Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity,” Journal of Surgical Oncology, vol. 104, no. 6, pp. 692–698, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-Y. Kim and H.-S. Bae, “A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP),” Gastric Cancer, vol. 4, no. 1, pp. 27–33, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Yonemura, X. de Aretxabala, T. Fujimura et al., “Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study,” Hepato-Gastroenterology, vol. 48, no. 42, pp. 1776–1782, 2001. View at Google Scholar · View at Scopus
  9. Y. Yonemura, Y. Endou, M. Shinbo et al., “Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery,” Journal of Surgical Oncology, vol. 100, no. 4, pp. 311–316, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Glehen, F. N. Gilly, C. Arvieux et al., “Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy,” Annals of Surgical Oncology, vol. 17, no. 9, pp. 2370–2377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. D. Yan, D. Black, P. H. Sugarbaker et al., “A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer,” Annals of Surgical Oncology, vol. 14, no. 10, pp. 2702–2713, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Jin-Yu, Y.-Y. Xu, Z. Sun et al., “Comparison different methods of intraoperative and intraperitoneal chemotherapy for patients with gastric cancer: a meta-analysis,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 9, pp. 4379–4385, 2012. View at Google Scholar
  13. J. Sun, Y. Song, Z. Wang et al., “Benefit of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials,” BMC Cancer, vol. 12, article 526, 2012. View at Publisher · View at Google Scholar
  14. Y. Yonemura, A. Elnemr, Y. Endou et al., “Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer,” World Journal of Gastrointestinal Oncology, vol. 2, no. 2, pp. 85–97, 2010. View at Publisher · View at Google Scholar
  15. F. Carboni, A. di Giorgio, L. di Lauro et al., “Criteri di appropriatezza clinica ed organizzativa nella diagnosi, terapia e follow-up delle carcinosi peritoneali,” SICO, 2012, http://www.sicoonline.org/00_allegati_news/15_CarcinosiPeritoneali.pdf.
  16. S. Pyrhonen, T. Kuitunen, P. Nyandoto, and M. Kouri, “Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer,” British Journal of Cancer, vol. 71, no. 3, pp. 587–591, 1995. View at Google Scholar · View at Scopus
  17. K. Hanazaki, Y. Mochizuki, T. Machida et al., “Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer,” Hepato-Gastroenterology, vol. 46, no. 26, pp. 1238–1243, 1999. View at Google Scholar · View at Scopus
  18. Y. Kodera, Y. Yamamura, Y. Shimizu et al., “Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection,” Journal of Surgical Oncology, vol. 72, no. 2, pp. 60–64, 1999. View at Google Scholar
  19. F. Roviello, S. Caruso, D. Marrelli et al., “Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments,” Surgical Oncology, vol. 20, no. 1, pp. e38–e54, 2011. View at Google Scholar
  20. F. Roviello, D. Marrelli, A. Neri et al., “Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity,” World Journal of Surgery, vol. 30, no. 11, pp. 2033–2040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Fujimoto, M. Takahashi, T. Mutou et al., “Successful intraperitoneal hyperthermic chemoperfusion for the prevention of post-operative peritoneal recurrence in patiens with advanced gastric carcinoma,” Cancer, vol. 85, no. 3, pp. 529–534, 1999. View at Google Scholar
  22. P. H. Sugarbaker, “Peritonectomy procedures,” Annals of Surgery, vol. 221, no. 1, pp. 29–42, 1995. View at Google Scholar · View at Scopus
  23. P. H. Sugarbaker, “Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis,” Seminars in Surgical Oncology, vol. 14, no. 3, pp. 254–261, 1998. View at Google Scholar
  24. P. H. Sugarbaker, “Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology,” in Peritoneal Carcinomatosis: Principles and Management, pp. 79–100, Kluwer Academic, Boston, Mass, USA, 1996. View at Google Scholar
  25. Y. Yonemura, N. Nojima, T. Kawamura et al., “Mechanisms of formation of peritoneal dissemination,” in Peritoneal Dissemination: Molecular Mechanisms and the Latest Therapy, pp. 1–46, Maeda Shoten, Kanazawa, Japan, 1998. View at Google Scholar
  26. J. H. Stewart IV, P. Shen, A. Edward et al., “Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions,” Annals of Surgical Oncology, vol. 12, no. 10, pp. 765–777, 2005. View at Publisher · View at Google Scholar
  27. R. S. Gill, D. Al-Adra, J. Nagendran et al., “Tretement of gastric cancer with peritoneal carcinomatosis by cytoredctive surgery and HIPEC: a systematic review of survival, mortality, and morbidity,” Journal of Surgical Oncology, vol. 104, no. 6, pp. 692–698, 2011. View at Publisher · View at Google Scholar
  28. Q.-M. Yang, T. Kawamura, H. Itoh et al., “Is PET-CT suitable for predicting lymph node status for gastric cancer?” Hepato-Gastroenterology, vol. 55, no. 82-83, pp. 782–785, 2008. View at Google Scholar · View at Scopus
  29. Japanese Research Society for Gastric Cancer, The General Rules for Gastric Cancer Study, Kanahara Shuppan, Tokyo, Japan, 1st edition, 1995.
  30. P. Jacquet and P. H. Sugarbaker, “Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis,” in Peritoneal Carcinomatosis: Principles of Management, P. H. Sugarbaker, Ed., pp. 359–374, Kluwer Academic, Boston, Mass, USA, 1996. View at Google Scholar
  31. L. Ansaloni, M. Lotti, and L. Campanati, “The prevention and treatement of peritoneal carcinomatosis from gastric cancer: a 2013 update,” Journal of Cancer Research & Therapy, vol. 1, no. 1, pp. 54–59, 2013. View at Google Scholar
  32. M. M. Heiss, P. Murawa, P. Koralewski et al., “The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II/III trial,” International Journal of Cancer, vol. 127, no. 9, pp. 2209–2221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Ströhlein, F. Lordick, D. Rüttinger et al., “Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial,” Onkologie, vol. 34, no. 3, pp. 101–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. I. T. Konstantinidis, C. Young, V. L. Tsikitis et al., “Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusione: the University of Arizona early experience,” World Journal of Gastrointestinal Surgery, vol. 4, no. 6, pp. 135–140, 2012. View at Publisher · View at Google Scholar
  35. A. Mizumoto, E. Canabay, M. Hiranoand et al., “Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan,” Gastroenterology Research and Practice, vol. 2012, Article ID 836425, 5 pages, 2012. View at Publisher · View at Google Scholar
  36. S. Fujimoto, M. Takahashi, T. Mutou et al., “Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery,” Cancer, vol. 79, no. 5, pp. 884–891, 1997. View at Google Scholar
  37. O. Glehen, V. Schreiber, E. Cotte et al., “Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer,” Archives of Surgery, vol. 139, no. 1, pp. 20–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Allum, A. Garofalo, M. Degiuli, and C. Schuhmacher, “The first European union network of excellence for gastric cancer conference, Rome, Italy, April 2008,” Gastric Cancer, vol. 12, no. 1, pp. 56–65, 2009. View at Publisher · View at Google Scholar · View at Scopus